AU1654900A - Bi-pyrrolidinylvinl (carba) cephalosporins - Google Patents
Bi-pyrrolidinylvinl (carba) cephalosporinsInfo
- Publication number
- AU1654900A AU1654900A AU16549/00A AU1654900A AU1654900A AU 1654900 A AU1654900 A AU 1654900A AU 16549/00 A AU16549/00 A AU 16549/00A AU 1654900 A AU1654900 A AU 1654900A AU 1654900 A AU1654900 A AU 1654900A
- Authority
- AU
- Australia
- Prior art keywords
- pyrrolidinylvinl
- carba
- cephalosporins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98122965 | 1998-12-03 | ||
EP98122965 | 1998-12-03 | ||
EP99119895 | 1999-10-07 | ||
EP99119895 | 1999-10-07 | ||
PCT/EP1999/009120 WO2000032605A1 (fr) | 1998-12-03 | 1999-11-25 | Bi-pyrrolidinylvinyl (carba) cephalosporines |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1654900A true AU1654900A (en) | 2000-06-19 |
Family
ID=26149851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU16549/00A Abandoned AU1654900A (en) | 1998-12-03 | 1999-11-25 | Bi-pyrrolidinylvinl (carba) cephalosporins |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR023065A1 (fr) |
AU (1) | AU1654900A (fr) |
CO (1) | CO5150174A1 (fr) |
PE (1) | PE20001402A1 (fr) |
WO (1) | WO2000032605A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60035925T2 (de) * | 1999-07-05 | 2008-05-15 | Basilea Pharmaceutica Ag | Verfahren zur Herstellung von Cephalosporin-Derivaten |
AU6267100A (en) * | 1999-07-07 | 2001-01-30 | F. Hoffmann-La Roche Ag | Vinylpyrrolidinone derivatives with substituted thiazole ring |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5883247A (en) * | 1996-06-10 | 1999-03-16 | Hoffmann-La Roche Inc. | Preparation of cephem and isooxacephem derivatives |
EP0831093A1 (fr) * | 1996-09-23 | 1998-03-25 | F. Hoffmann-La Roche Ag | Dérivés de 1-carba-(déthia)-céphalosporine |
EP0838465A1 (fr) * | 1996-10-22 | 1998-04-29 | F. Hoffmann-La Roche Ag | Dérivés de (lactamylvinyl)cephalosporin pyridinium substitués, leur préparation et leur utilisation comme antibiotiques |
ATE354577T1 (de) * | 1996-11-06 | 2007-03-15 | Basilea Pharmaceutica Ag | Vinylpyrrolidinon-cephalosporin-derivate |
TW415949B (en) * | 1996-12-19 | 2000-12-21 | Hoffmann La Roche | Vinyl pyrrolidine cephalosporin derivatives with basic substituents |
US6150350A (en) * | 1997-09-15 | 2000-11-21 | Hoffman-La Roche Inc. | Antimicrobial compositions |
-
1999
- 1999-11-25 AU AU16549/00A patent/AU1654900A/en not_active Abandoned
- 1999-11-25 WO PCT/EP1999/009120 patent/WO2000032605A1/fr active Application Filing
- 1999-11-29 PE PE1999001191A patent/PE20001402A1/es not_active Application Discontinuation
- 1999-11-30 CO CO99075208A patent/CO5150174A1/es unknown
- 1999-12-01 AR ARP990106105A patent/AR023065A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000032605A1 (fr) | 2000-06-08 |
CO5150174A1 (es) | 2002-04-29 |
AR023065A1 (es) | 2002-09-04 |
PE20001402A1 (es) | 2000-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3485999A (en) | Neo-tryptophan | |
AU2623899A (en) | Novel thiobenzamides | |
AU4260199A (en) | Novel compounds | |
AU2014800A (en) | Novel compounds | |
AU5980899A (en) | Novel compounds | |
AU2350199A (en) | Novel aminoorganofunctionalsiloxanes | |
AU5290999A (en) | Simplified window-raiser - | |
AU3437799A (en) | City-car | |
AU3522399A (en) | Carvedilol-galenics | |
AU4814699A (en) | Novel compounds | |
AU4037699A (en) | Novel aryl-hydro naphthalenal kanamines | |
AU3253699A (en) | Myxochelines | |
AU5407599A (en) | Sphingolipid-desaturase | |
AU5516599A (en) | Substituted 3-aryl-pyrazoles | |
AU1707599A (en) | Retinoid-glitazone combinations | |
AU2187799A (en) | Novel taxaneterpine compounds | |
AU2609599A (en) | Sensor-coupling | |
AU2724799A (en) | Novel endo-xylogalacturonase | |
AU4511499A (en) | Substituted cyclooctadepsipeptides | |
AU3204999A (en) | Futureball | |
AU1654900A (en) | Bi-pyrrolidinylvinl (carba) cephalosporins | |
AU4507899A (en) | Substituted n-aryl-o-alkyl-carbamates | |
AU1055399A (en) | Rollerboard | |
AU5340198A (en) | Cephem compounds | |
AU5223199A (en) | Bathtub-bathseat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |